Suchergebnisse - "Brain Neoplasms"

PubPharm (8.717)

91

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients

enthalten in: Cancer | 2024

von Ranjan, S. | Leung, D. | Ghiaseddin, A. | +15

92

External border zone may be correlated with radiation necrosis after radiosurgery in metastatic brain tumor

enthalten in: World neurosurgery | 2024

von Lee, C. | Yoon, S. | Hwang, J. | +6

93

Tumor Related Epilepsy : Tumor Related Epilepsy

enthalten in: ClinicalTrials.gov | 2024

94

Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases : A Pilot Study to Evaluate Neuropsychological Outcome Measures and Their Relationship With Prognosis in Patients Receiving Radiation Therapy for Brain Metastases

enthalten in: ClinicalTrials.gov | 2024

95

Natural History of and Specimen Banking for People With Tumors of the Central Nervous System : Evaluation of the Natural History of and Specimen Banking for Patients With Tumors of the Central Nervous System

enthalten in: ClinicalTrials.gov | 2024

96

Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases : A Phase 1 Study of Trametinib in Combination With Radiation Therapy for Brain Metastases

enthalten in: ClinicalTrials.gov | 2024

97

Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI) : Investigating Metabolic Characteristics of Intracranial Malignancy In Vivo Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)

enthalten in: ClinicalTrials.gov | 2024

98

Evidence-based clinical recommendations for hypofractionated radiotherapy : exploring efficacy and safety - Part 1. Brain and head and neck

enthalten in: Radiation oncology journal | 2024

von Sung, S. | Song, J. | Kim, B. | +6

99

Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors : A Phase 1/2 Study of PBI-200 in Subjects With NTRK-Fusion-Positive Advanced or Metastatic Solid Tumors

enthalten in: ClinicalTrials.gov | 2024

100

A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors : A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors

enthalten in: ClinicalTrials.gov | 2024